Clinical Trial Update: Immunotherapy in Combination With Chemotherapy in Small-cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating immunotherapy combined with chemotherapy in small-cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: Hellenic Cooperative Oncology Group | Conditions: Small Cell Lung Carcinoma | Phase 2 | Status: UNKNOWN